Bystander suppression in experimental autoimmune encephalomyelitis: where and how does it occur?
- 31 December 1998
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 149 (9) , 820-827
- https://doi.org/10.1016/s0923-2494(99)80010-8
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Phase 1 trial of transforming growth factor beta 2 in chronic progressive MSNeurology, 1998
- Male SJL mice do not relapse after induction of EAE with PLP 139-151Journal of Neuroscience Research, 1996
- Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic proteinNature, 1996
- Peripheral deletion of antigen-reactive T cells in oral toleranceNature, 1995
- Antigen‐driven tissue‐specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein‐induced experimental autoimmune encephalomyelitis in the SJL mouseEuropean Journal of Immunology, 1994
- Published by American Association for the Advancement of Science (AAAS) ,1994
- Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortexJournal of Neuroimmunology, 1993
- Transforming growth factor-beta 1 (TGF-β1) expression and regulation in rat cortical astrocytesJournal of Neuroimmunology, 1992
- Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals.Journal of Clinical Investigation, 1991
- Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtypeCellular Immunology, 1989